Stocks · News reference

Cannara Biotech Reports Q3 2026 Results: Full Earnings Call Transcript

Jul 15, 2026, 3:58 PMBenzinga Insights

Cannara Biotech (TSX:LOVE) released third-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

TSX:LOVE

Source: benzinga
Observed: Jul 15, 2026, 3:58 PM
Checked: Jul 15, 2026, 3:58 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaJul 15, 2026, 11:20 AMBenzinga Newsdesk
Cannara Biotech Q3 EPS $0.05 Beats $0.03 Estimate, Sales $31.828M Beat $31.233M Estimate
Cannara Biotech (TSX:LOVE) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 25 percent increase over earnings of $0.04 per share from the same
Read original at benzinga
TSX:LOVE

Cannara Biotech Reports Q3 2026 Results: Full Earnings Call Transcript

Connected markets

Related headlines

Cannara Biotech Q3 EPS $0.05 Beats $0.03 Estimate, Sales $31.828M Beat $31.233M Estimate